<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Main causes of FSGS</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Main causes of FSGS</h1>
<div class="graphic"><div class="figure"><div class="ttl">Main causes of FSGS</div><div class="cntnt"><table cellspacing="0"><colgroup width="100%"></colgroup> <tbody> <tr> <td class="subtitle1_single">Primary FSGS</td> </tr> <tr> <td class="indent1">Circulating podocyte-toxic factor(s)</td> </tr> <tr> <td class="subtitle1_single">Secondary FSGS</td> </tr> <tr> <td class="indent1">Maladaptive response to hyperfiltration</td> </tr> <tr> <td class="indent2">Reduced nephron mass</td> </tr> <tr> <td class="indent2">Unilateral renal agenesis</td> </tr> <tr> <td class="indent2">Oligomeganephronia</td> </tr> <tr> <td class="indent2">Severe obesity</td> </tr> <tr> <td class="indent2">Low birth weight</td> </tr> <tr> <td class="indent1">Drugs and toxins</td> </tr> <tr> <td class="indent2">Heroin</td> </tr> <tr> <td class="indent2">Interferon (alpha, beta, gamma)</td> </tr> <tr> <td class="indent2">Bisphosphonates (eg, pamidronate)</td> </tr> <tr> <td class="indent2">Anabolic steroids</td> </tr> <tr> <td class="indent2">mTOR inhibitors</td> </tr> <tr> <td class="indent2">Calcineurin inhibitors</td> </tr> <tr> <td class="indent2">Anthracyclines</td> </tr> <tr> <td class="indent2">Lithium</td> </tr> <tr> <td class="indent1">Viruses</td> </tr> <tr> <td class="indent2">HIV</td> </tr> <tr> <td class="indent2">Parvovirus B19</td> </tr> <tr> <td class="indent2">Simian virus 40</td> </tr> <tr> <td class="indent2">Cytomegalovirus</td> </tr> <tr> <td class="indent2">Epstein-Barr virus</td> </tr> <tr> <td class="indent1">Other causes</td> </tr> <tr> <td class="indent2">Healing phase of focal proliferative glomerulonephritis (ANCA-associated vasculitis, IgA nephropathy, lupus nephritis), membranous nephropathy</td> </tr> <tr> <td class="indent2">Sickle cell anemia</td> </tr> <tr> <td class="indent2">Thrombotic microangiopathy</td> </tr> <tr> <td class="indent2">Fabry disease</td> </tr> <tr> <td class="indent2">Glucose-6-phosphatase deficiency (glycogen storage disease I, von Gierke disease)</td> </tr> <tr> <td class="indent2">Hemophagocytic syndrome</td> </tr> <tr> <td class="indent2">Fibrillary glomerulonephritis</td> </tr> <tr> <td class="subtitle1_single">Genetic FSGS (kidney limited and syndromic)</td> </tr> <tr> <td class="indent1">Mutations in slit diaphragm complex genes: <em>NPHS1</em>* (nephrin), <em>NPHS2</em>* (podocin), <em>CD2AP</em>*<sup>¶</sup>, <em>TRPC6</em><sup>¶</sup>, <em>PTPRO</em>* (<em>GLEPP1</em>), <em>MYO1E</em>*</td> </tr> <tr> <td class="indent1">Mutations in cytoskeleton genes: <em>ACTN4</em><sup>¶</sup>, <em>MYO1E</em>*, <em>INF2</em><sup>¶</sup>, <em>ARHGAP24</em><sup>¶</sup>, <em>ARHGDIA</em>*, <em>MYH9</em><sup>¶</sup> (Epstein syndrome, Fechtner syndrome), <em>ITGB4</em>*</td> </tr> <tr> <td class="indent1">Mutations in cell matrix genes: <em>COL4A3</em>, <em>COL4A4</em>, <em>COL4A5</em><sup>Δ</sup>, <em>LAMB2</em>* (Pierson syndrome)</td> </tr> <tr> <td class="indent1">Mutations in genes involved in DNA repair, transcription, or nuclear transport: <em>WT1</em><sup>¶</sup> (Denys-Drash syndrome, Frasier syndrome), <em>NUP93</em>, <em>XPO5</em> (exportin 5), <em>PAX2</em>, <em>LMX1B</em>* (Nail-patella syndrome), <em>WDR73</em> (Galloway-Mowat syndrome, nephro-cerebellar syndrome), <em>LMNA</em> (partial lipodystrophy), <em>SMARCAL1</em>*</td> </tr> <tr> <td class="indent1">Mutations in genes involved in cell signaling: <em>PLCE1</em>*, <em>TRPC6</em><sup>¶</sup>, <em>KANK4</em></td> </tr> <tr> <td class="indent1">Mutations in lysosome genes: <em>SCARB2</em>* (action myoclonus)</td> </tr> <tr> <td class="indent1">Mutations in cilia genes: <em>TTC21B</em></td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>FSGS: focal segmental glomerulosclerosis; 
        mTOR: mammalian (mechanistic) target of rapamycin; 
        ANCA: antineutrophil cytoplasmic autoantibodies; 
        IgA: immunoglobulin A.</p>
<p>* Pattern of inheritance in the most common genetic forms: Recessive.</p>
<p>¶ Pattern of inheritance in the most common genetic forms: Autosomal dominant.</p>
    
    Δ Pattern of inheritance in the most common genetic forms: Monogenic (X-linked/autosomal) and digenic inheritance described.</div><div class="graphic_reference">Adapted from: De Vriese AS, Sethi S, Nath KA, et al. Differentiating primary, genetic, and secondary FSGS in adults: A clinicopathologic approach. J Am Soc Nephrol 2018; 29:759.</div><div id="graphicVersion">Graphic 118939 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
